Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Low HDL-c”

31 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 31 results

Large-scale testing (Phase 3)Study completedNCT05079919
What this trial is testing

Olezarsen (ISIS 678354) Administered to Participants With Severe Hypertriglyceridemia

Who this might be right for
Severe Hypertriglyceridemia
Ionis Pharmaceuticals, Inc. 617
Not applicableStudy completedNCT00931320
What this trial is testing

Investigation Into the RAtio of LDL-CHolestEroL to HDL-Cholesterol Improvement After Statin Treatment in Korean Patients

Who this might be right for
Dyslipidemias
AstraZeneca 3,000
Testing effectiveness (Phase 2)Study completedNCT00748852
What this trial is testing

Safety Study of JTT-302 in Subjects With Low HDL-C Levels

Who this might be right for
Dyslipidemia
Akros Pharma Inc. 103
Not applicableStudy completedNCT01245738
What this trial is testing

Effect of Statins on Lipid Levels Following the First Acute Coronary Event (MK-0000-204)

Who this might be right for
DyslipidemiasHypercholesterolemiaHypertriglyceridemia+2 more
Merck Sharp & Dohme LLC 635
Large-scale testing (Phase 3)Study completedNCT00389896
What this trial is testing

A Crossover Study to Evaluate the Efficacy of Simvastatin in Elevating HDL-C Levels in Patients With Type 2 Diabetes (0733-216)(COMPLETED)

Who this might be right for
HDL Cholesterol
Organon and Co 150
Not applicableLooking for participantsNCT06439654
What this trial is testing

Atlantic Lipid Lowering Treatment Optimization Program

Who this might be right for
Familial HypercholesterolemiaLipoprotein Types--Lp System Lp(A) HyperlipoproteinemiaApolipoprotein B 100, Familial Defective+2 more
Atlantic Health System 250
Testing effectiveness (Phase 2)Study completedNCT00697203
What this trial is testing

Assess the Effect of RO4607381 in Patients With Relatively Low Levels of High Density Lipoprotein-Cholesterol (HDL-C)

Who this might be right for
Dyslipidemia
Hoffmann-La Roche 292
Not applicableStudy completedNCT06463990
What this trial is testing

Influence of TyG Index and TG/HDL-C Ratio on Fetal Macrosomia

Who this might be right for
Fetal MacrosomatiaLipid Metabolism DisordersHyperlipidemias
Ankara Etlik City Hospital 302
Large-scale testing (Phase 3)Ended earlyNCT01414166
What this trial is testing

Niacin/Laropiprant Tablet for South and Southeast Asians With Low High-Density Lipoprotein Cholesterol (LDL-C) at Risk for Cardiovascular Disease (MK-0524A-108)

Who this might be right for
Dyslipidemia
Merck Sharp & Dohme LLC 244
Post-approval studies (Phase 4)UnknownNCT00736463
What this trial is testing

Crossover of Higher Dose Statins in Patients With Low High-density Lipoproteins Cholesterol (HDLc)

Who this might be right for
HDL Cholesterol
Oregon Health and Science University 80
Testing effectiveness (Phase 2)Study completedNCT00749788
What this trial is testing

Efficacy and Safety Study of JTT-302 in Subjects With Low HDL-C Levels

Who this might be right for
Dyslipidemia
Akros Pharma Inc. 150
Early research (Phase 1)Study completedNCT01448824
What this trial is testing

LY2484595 on Pharmacokinetics in Healthy Participants

Who this might be right for
Healthy Participants
Eli Lilly and Company 82
Post-approval studies (Phase 4)Ended earlyNCT01308203
What this trial is testing

Lipid Efficacy of the Extended Release Niacin/Laropiprant Combination in Patients With Cardiovascular Disease

Who this might be right for
Coronary Artery DiseaseDyslipidemias
Daniel A. Siniawski 32
Not applicableStudy completedNCT01159613
What this trial is testing

Do Low High Density Lipoprotein (HDL) Levels Predict Treatment Outcome in Patients With Chronic Hepatitis C Viral Infection?

Who this might be right for
Chronic Hepatitis C Viral Infection
Ziv Hospital 80
Testing effectiveness (Phase 2)Study completedNCT00327002
What this trial is testing

A Mechanistic Study of the Effects of LY518674 on High-Density Lipoprotein Cholesterol (HDL-C) Metabolism

Who this might be right for
Metabolic Syndrome X
University of Pennsylvania 40
Not applicableEnded earlyNCT00525083
What this trial is testing

Protein and Phospholipid Analysis of HDL in Patients With Very High Serum Levels of HDL-C

Who this might be right for
Hyperlipidemia
Vanderbilt University Medical Center 19
Large-scale testing (Phase 3)Study completedNCT04998981
What this trial is testing

Evaluate the Efficacy and Safety of K-877 in Chinese Patients With High TG and Low HDL-C

Who this might be right for
Hyperlipidemia
Kowa Company, Ltd. 353
Testing effectiveness (Phase 2)Study completedNCT01105975
What this trial is testing

LY2484595 in Patients With High LDL-C or Low HDL-C

Who this might be right for
Dyslipidemia
Eli Lilly and Company 398
Large-scale testing (Phase 3)Study completedNCT01860729
What this trial is testing

The Safety and Efficacy of Anacetrapib (MK-0859) Among Participants With Hypercholesterolemia When Added to Ongoing Statin Therapy (MK-0859-022)

Who this might be right for
Hypercholesterolemia
Merck Sharp & Dohme LLC 589
Not applicableStudy completedNCT01031758
What this trial is testing

Reverse Cholesterol Transport (RCT) Study

Who this might be right for
Healthy
University of Pennsylvania 18
Load More Results